NCT02086760

Brief Summary

Diagnosis and follow up of hydronephrosis is actually based on repeat ultrasonography and scintigraphy wich is a binding exam for children. We wanted to evaluate the use of ultrasonography sensibilized by an oral hydration and to determine its efficiency to detect which hydronephrosis need a surgery or not.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 18, 2014

Completed
23 days until next milestone

First Posted

Study publicly available on registry

March 13, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

October 2, 2015

Status Verified

October 1, 2015

Enrollment Period

2.5 years

First QC Date

February 18, 2014

Last Update Submit

October 1, 2015

Conditions

Keywords

hydronephrosis

Outcome Measures

Primary Outcomes (1)

  • Similarity between the decision of the treating surgeon and the independent surgeon about the subject's medical care

    The primary outcome measure is a composite outcome measure consisting of multiple measures. Indeed, the treating surgeon will make a decision (ie to operate or not) upon the clinical exam, ultrasonography with oral hydratation and scintigraphy results. The independent surgeon will only be given data from the clinical exam and the ultrasonography. For ultrasonography, the following parameters will be measured: cortical thickness, anteroposterior renal pelvis diameter, calyx diameter, kidney echogenicity, kidney size. The measures will be done before, 30 min and 90 min following oral hydration. For scintigraphy, the relative kidney function, T1/2, Tmax and NORA will be analyzed. The result will be reported as a single value, ie: * the treating surgeon's decision and the independent surgeon's decision are similar (=1) or * the treating surgeon's decision and the independent surgeon's decision are not similar (=0)

    V2 (Age of 6 months)

Secondary Outcomes (1)

  • Similarity between the decision of the treating surgeon and the independent surgeon about the subject's medical care

    Between V0 (age: 30 days ) and V2 (age: 6 months)

Study Arms (1)

Ultrasonography sensibilized by oral hydratation

EXPERIMENTAL

Ultrasonography before, 30 min and 90 min following hydratation.

Other: Ultrasonography with oral hydrationRadiation: Scintigraphy

Interventions

Before, 30 min and 90 min following oral hydration

Ultrasonography sensibilized by oral hydratation
ScintigraphyRADIATION
Ultrasonography sensibilized by oral hydratation

Eligibility Criteria

AgeUp to 30 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • child of 30 days old or less
  • unilateral or bilateral hydronephrosis (pelvis \> 5mm )

You may not qualify if:

  • complex uropathy
  • diuretic administration 6 hours prior to ultrasonography or scintigraphy
  • oral feeding trouble

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Chirurgie Pédiatrique - Hôpital de Hautepierre- CHRU Strasbourg

Strasbourg, 67098, France

Location

MeSH Terms

Conditions

Hydronephrosis

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Officials

  • Isabelle LACREUSE, MD

    Hôpitaux Universitaires de Strasbourg

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 18, 2014

First Posted

March 13, 2014

Study Start

May 1, 2014

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

October 2, 2015

Record last verified: 2015-10

Locations